Solinacin Succinate Tablets are effective in the treatment of symptoms such as urinary incontinence associated with patients with overactive bladder syndrome. Solinacin is a competitive muscarinic receptor antagonist. Muscarinic receptors play an important role in a number of primarily cholinergically mediated functions, including contraction of bladder smooth muscle and stimulation of salivary secretion. It is used for the treatment of urinary incontinence and/or symptoms of urinary frequency and urgency associated with overactive bladder syndrome. Adverse reactions to Solynasin Succinate Tablets include blurred vision, constipation, nausea, and dyspepsia. Solynasin Succinate Tablets are contraindicated in people who are allergic to Solynasin Succinate Tablets, urinary retention, severe gastrointestinal disorders, myasthenia gravis, narrow angle glaucoma, and people with severe hepatic dysfunction. It should also be noted that the safety and efficacy of the drug in pregnant women, lactating women, and children have not been established, and the drug should be avoided. If you need to use Solinacin Succinate Tablets, it is recommended to consult a professional doctor and follow the doctor’s instructions to standardize the treatment, not to use the drug arbitrarily.